5y outcomes SOC Axi-Cel: US real world data, Jain et al • All 3rd+ line, 298 leucopheresed pts • 5y PFS/OS 29%/40% • 5y NRM 16% (infn/ 2nd malig dominant) • NRM higher in > 60y Worrying NRM. Could this be ⬇️ when used 2nd line (less prior Rx)? #lymsm ascopubs.org/doi/10.1200/JC…

Join us for this unique The EBMT event about all things transplant and cellular therapy in adults and paediatrics Opportunity to learn everything in 3 days Excellent case and poster presentations Network and more in beautiful Barcelona Register: ebmt.org/events/9th-int…

Great work to create this proposal for revised criteria for anaemia response in MF by a group of experts. I quite like that minor AnResp and StableAn are defined Minor criticism: they are quite complicated and might not be easily applicable in the RW ashpublications.org/blood/article/…

Instagram just became more interesting for me!

The discovery of penicillin is one of the greatest achievements in modern medicine How it started and how it’s going, a thread🧵

Very pleased to share our work on development of natural language processing pipeline to assess cardiovascular risk and thrombotic complications in MPN. Machine learning approach allowing assessment of health records of >900 patients and >23000 documents onlinelibrary.wiley.com/doi/full/10.10…

Winner - Best Consultant, HCC Awards 2023 'We’re very fortunate with the support we get and with the facilities we have, and that we’re able to provide the level of care that we do, which I think is exceptional’ Satyen Gohil – Haematology Consultant #HCCawards #HCCis30 UCLH

I don’t know what this means but I’m calling Micro for advice

The case for life in planet Venus becomes more compelling! amp.cnn.com/cnn/2024/07/29…

Jurassic park was on to something😅

Momelotinib for the treatment of myelofibrosis ow.ly/QNCR50SYKYJ #BloodSpotlight #myeloidneoplasia

🚨New Paper Alert🚨Excited to share our research on human HSC heterogeneity, now published in Science Immunology! Check out the full paper here: science.org/doi/10.1126/sc…. See some highlights below.

Platelets are way more interesting than most people think Great commentary ashpublications.org/thehematologis…

🚨Job opportunity for bioinformatician: Come and join the Cancer Grand Challenges NexTGen team to develop T cell #immunotherapy for #childhoodcancer. For more information and to apply: ucl.ac.uk/work-at-ucl/se…

Totally thrilled to receive a Senior Science and Innovation at Cancer Research UK Fellowship. Extremely grateful to work with an amazing team & brilliant colleagues MRC WIMM University of Oxford and excited about what this funding will enable us to achieve over the next 6yrs!

Amazing news! Many of congratulations !

At #ISA2024, Jahanzaib Khwaja of UCLH spoke on the safety and efficacy of belantamab mafodotin in systemic AL #Amyloidosis. Watch the interview here: 👉 ow.ly/rHom50T9yVU 👈 #ISA_2024 The International Society Of Amyloidosis #ISA24 #ImmunoOnc #HemOnc

Registration is open for the BSH - Haematology IMT day in October. Aimed at those interested in haematology as a career and those who want to upskill their haem knowledge. BSH membership is FREE to IMT doctors, so joining allows you to register at member rate! b-s-h.org.uk/education/conf…

Today marks the start of Blood Cancer Awareness Month, and an important day for many in our community, World CLL Day 🩸 We’re shining a light on chronic lymphocytic leukaemia (CLL) - a slow growing, chronic blood cancer that can often be overlooked 👇